Annual Short Term Debt
$2.94 M
-$1.87 M-38.89%
30 June 2024
Summary:
Renovaro Biosciences annual short term debt is currently $2.94 million, with the most recent change of -$1.87 million (-38.89%) on 30 June 2024. During the last 3 years, it has risen by +$2.65 million (+907.01%). RENB annual short term debt is now -38.89% below its all-time high of $4.82 million, reached on 30 June 2023.RENB Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.11 M
+$166.50 K+5.65%
30 September 2024
Summary:
Renovaro Biosciences quarterly short term debt is currently $3.11 million, with the most recent change of +$166.50 thousand (+5.65%) on 30 September 2024. Over the past year, it has dropped by -$765.80 thousand (-19.75%). RENB quarterly short term debt is now -59.08% below its all-time high of $7.60 million, reached on 31 March 2024.RENB Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.9% | -19.8% |
| 3 y3 years | +907.0% | -38.2% |
| 5 y5 years | +100.0% | +1091.5% |
RENB Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.9% | +907.0% | -59.1% | +122.4% |
| 5 y | 5 years | -38.9% | -59.1% | +1091.5% | |
| alltime | all time | -38.9% | -59.1% |
Renovaro Biosciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.11 M(+5.7%) |
| June 2024 | $2.94 M(-38.9%) | $2.94 M(-61.3%) |
| Mar 2024 | - | $7.60 M(+13.0%) |
| Dec 2023 | - | $6.73 M(+73.5%) |
| Sept 2023 | - | $3.88 M(-19.5%) |
| June 2023 | $4.82 M(+231.5%) | - |
| June 2023 | - | $4.82 M(-22.4%) |
| Mar 2023 | - | $6.21 M(+25.9%) |
| Dec 2022 | - | $4.93 M(+252.4%) |
| Sept 2022 | - | $1.40 M(-3.8%) |
| June 2022 | $1.45 M(+397.1%) | $1.45 M(-76.9%) |
| Mar 2022 | - | $6.28 M(+24.8%) |
| Dec 2021 | - | $5.03 M(+1588.9%) |
| Sept 2021 | - | $297.90 K(+1.9%) |
| June 2021 | $292.40 K(+7.8%) | $292.40 K(+1.9%) |
| Mar 2021 | - | $287.00 K(+1.9%) |
| Dec 2020 | - | $281.70 K(+1.9%) |
| Sept 2020 | - | $276.50 K(+1.9%) |
| June 2020 | $271.30 K(>+9900.0%) | $271.30 K(+1.9%) |
| Mar 2020 | - | $266.20 K(+2.0%) |
| Dec 2019 | - | $261.10 K(+2.0%) |
| Sept 2019 | - | $256.10 K(>+9900.0%) |
| June 2019 | $0.00 | $0.00(-100.0%) |
| Dec 2017 | - | $209.30 K(-57.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $496.00 K(-76.3%) |
| June 2017 | $2.09 M(+1930.9%) | $2.09 M(+374.8%) |
| Mar 2017 | - | $440.10 K(+326.5%) |
| Dec 2016 | - | $103.20 K(-0.3%) |
| Sept 2016 | - | $103.50 K(+0.6%) |
| June 2016 | $102.90 K(+2.3%) | $102.90 K(+0.2%) |
| Mar 2016 | - | $102.70 K(+1.3%) |
| Dec 2015 | - | $101.40 K(+0.2%) |
| Sept 2015 | - | $101.20 K(+1.9%) |
| June 2015 | $100.60 K(+0.6%) | - |
| Mar 2015 | - | $99.30 K(-0.7%) |
| Dec 2014 | $100.00 K(+57.0%) | $100.00 K(-93.8%) |
| Sept 2014 | - | $1.61 M(-6.2%) |
| June 2014 | - | $1.72 M(+0.7%) |
| Mar 2014 | - | $1.71 M(+2103.1%) |
| Dec 2013 | - | $77.40 K(+5.0%) |
| Sept 2013 | - | $73.70 K(+14.8%) |
| June 2013 | - | $64.20 K(+0.8%) |
| Mar 2013 | $63.70 K(+134.2%) | $63.70 K(+16.5%) |
| Dec 2012 | - | $54.70 K(+507.8%) |
| Sept 2012 | - | $9000.00(+80.0%) |
| June 2012 | - | $5000.00(-81.6%) |
| Mar 2012 | $27.20 K | $27.20 K(+444.0%) |
| Dec 2011 | - | $5000.00 |
FAQ
- What is Renovaro Biosciences annual short term debt?
- What is the all time high annual short term debt for Renovaro Biosciences?
- What is Renovaro Biosciences annual short term debt year-on-year change?
- What is Renovaro Biosciences quarterly short term debt?
- What is the all time high quarterly short term debt for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly short term debt year-on-year change?
What is Renovaro Biosciences annual short term debt?
The current annual short term debt of RENB is $2.94 M
What is the all time high annual short term debt for Renovaro Biosciences?
Renovaro Biosciences all-time high annual short term debt is $4.82 M
What is Renovaro Biosciences annual short term debt year-on-year change?
Over the past year, RENB annual short term debt has changed by -$1.87 M (-38.89%)
What is Renovaro Biosciences quarterly short term debt?
The current quarterly short term debt of RENB is $3.11 M
What is the all time high quarterly short term debt for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly short term debt is $7.60 M
What is Renovaro Biosciences quarterly short term debt year-on-year change?
Over the past year, RENB quarterly short term debt has changed by -$765.80 K (-19.75%)